DE60220661D1 - Transdermales pflaster zur verabreichung von fentanyl - Google Patents

Transdermales pflaster zur verabreichung von fentanyl

Info

Publication number
DE60220661D1
DE60220661D1 DE60220661T DE60220661T DE60220661D1 DE 60220661 D1 DE60220661 D1 DE 60220661D1 DE 60220661 T DE60220661 T DE 60220661T DE 60220661 T DE60220661 T DE 60220661T DE 60220661 D1 DE60220661 D1 DE 60220661D1
Authority
DE
Germany
Prior art keywords
transdermales
fentanyl
plaster
administration
transdermales plaster
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60220661T
Other languages
English (en)
Other versions
DE60220661T2 (de
Inventor
Subramanian S Venkatraman
Shaoling Li
Robert M Gale
Jane Stepic
Osdol William W Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23058257&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60220661(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of DE60220661D1 publication Critical patent/DE60220661D1/de
Publication of DE60220661T2 publication Critical patent/DE60220661T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
DE60220661T 2001-03-16 2002-03-15 Transdermales pflaster zur verabreichung von fentanyl Expired - Lifetime DE60220661T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27683701P 2001-03-16 2001-03-16
US276837P 2001-03-16
PCT/US2002/007701 WO2002074286A1 (en) 2001-03-16 2002-03-15 Transdermal patch for administering fentanyl

Publications (2)

Publication Number Publication Date
DE60220661D1 true DE60220661D1 (de) 2007-07-26
DE60220661T2 DE60220661T2 (de) 2008-02-14

Family

ID=23058257

Family Applications (3)

Application Number Title Priority Date Filing Date
DE02715112T Pending DE02715112T1 (de) 2001-03-16 2002-03-15 Transdermales pflaster zur verabreichung von fentanyl
DE60220661T Expired - Lifetime DE60220661T2 (de) 2001-03-16 2002-03-15 Transdermales pflaster zur verabreichung von fentanyl
DE20221841U Expired - Lifetime DE20221841U1 (de) 2001-03-16 2002-03-15 Transdermal-Pflaster zum Verabreichen von Fentanyl

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE02715112T Pending DE02715112T1 (de) 2001-03-16 2002-03-15 Transdermales pflaster zur verabreichung von fentanyl

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE20221841U Expired - Lifetime DE20221841U1 (de) 2001-03-16 2002-03-15 Transdermal-Pflaster zum Verabreichen von Fentanyl

Country Status (22)

Country Link
US (11) US20030026829A1 (de)
EP (1) EP1381352B1 (de)
JP (7) JP5354763B2 (de)
KR (1) KR100904158B1 (de)
CN (2) CN100508974C (de)
AT (4) ATE364380T1 (de)
CA (1) CA2440884C (de)
CY (1) CY1106834T1 (de)
CZ (1) CZ307857B6 (de)
DE (3) DE02715112T1 (de)
DK (2) DK1381352T3 (de)
ES (1) ES2270746T3 (de)
FI (2) FI6962U1 (de)
HK (1) HK1068545A1 (de)
IL (3) IL157822A0 (de)
MX (1) MXPA03008349A (de)
NZ (1) NZ528148A (de)
PL (1) PL363079A1 (de)
PT (1) PT1381352E (de)
RU (2) RU2708563C2 (de)
WO (1) WO2002074286A1 (de)
ZA (1) ZA200308026B (de)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
MXPA03008349A (es) * 2001-03-16 2004-10-15 Johnson & Johnson Parche transdermico para administrar fentanilo.
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
TW200404581A (en) * 2002-04-23 2004-04-01 Alza Corp Transdermal analgesic systems with reduced abuse potential
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
DE10223835A1 (de) * 2002-05-28 2003-12-11 Labtec Gmbh Pflaster, enthaltend Fentanylum
EP1894563B2 (de) * 2002-05-28 2022-04-27 ratiopharm GmbH Pflaster, enthaltend Fentanylum
EP1386604A1 (de) * 2002-07-30 2004-02-04 Schwarz Pharma Ag Verbessertes transdermales Verabreichungssystem
TWI296531B (en) 2002-10-18 2008-05-11 Hisamitsu Pharmaceutical Co Transdermal adhesive preparations for topical administration of fentanyl
US20040086551A1 (en) 2002-10-30 2004-05-06 Miller Kenneth J. Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
PL378076A1 (pl) * 2003-02-07 2006-02-20 Lts Lohmann Therapie-Systeme Ag Transdermalny system terapeutyczny nadający się do użycia ciepła w celu przyspieszenia przenikania substancji czynnych i jego zastosowanie
US8778382B2 (en) * 2003-04-30 2014-07-15 Purdue Pharma L.P. Tamper resistant transdermal dosage form
US8790689B2 (en) 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
US20040219195A1 (en) * 2003-04-30 2004-11-04 3M Innovative Properties Company Abuse-resistant transdermal dosage form
US7182955B2 (en) * 2003-04-30 2007-02-27 3M Innovative Properties Company Abuse-resistant transdermal dosage form
EP2269606A3 (de) 2003-10-30 2012-04-25 ALZA Corporation Transdermale analgesische Systeme mit reduziertem Missbrauchspotential
EP1530967B1 (de) 2003-11-13 2006-05-03 Ferring B.V. Blisterverpackung und feste Dosierungsform enthaltend Desmopressin
WO2006023644A2 (en) * 2004-08-20 2006-03-02 3M Innovative Properties Company Transdermal drug delivery device with translucent protective film
EP1796613A4 (de) * 2004-09-08 2008-10-01 Dermatrends Inc Transdermale abgabe von hydrophoben biologisch wirksamen mitteln
AU2012201164B2 (en) * 2004-10-21 2014-07-24 Durect Corporation Transdermal delivery systems
SI1814531T1 (sl) 2004-10-21 2010-10-29 Durect Corp Transdermalni dostavni sistem
US8252319B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
GB0509276D0 (en) * 2005-05-06 2005-06-15 Univ Cranfield Synthetic receptor
DK1895994T3 (da) 2005-05-13 2010-12-20 Alza Corp Multilagsmedikamentleveringssystem med barriere mod reservoirmaterialeflow
TWI419717B (zh) * 2005-06-17 2013-12-21 Altea Therapeutics Corp 滲透傳送系統及其使用方法
WO2007011987A2 (en) * 2005-07-18 2007-01-25 Alza Corporation Device and method for increasing the throughput of irritation testing of transdermal formulations
EP2308480B1 (de) * 2005-09-23 2014-08-13 ALZA Corporation Polyacrylatformulierung mit hoher Beladung von verstärkenden Substanzen für transdermale Anwendungen
WO2007035941A2 (en) * 2005-09-23 2007-03-29 Alza Corporation Transdermal galantamine delivery system
US20070134310A1 (en) * 2005-09-23 2007-06-14 Nedberge Diane E Transdermal risperidone delivery system
CA2642338A1 (en) * 2006-02-13 2007-08-23 Aveva Drug Delivery Systems Adhesive preparation comprising sufentanil and methods of using the same
WO2007121949A1 (en) * 2006-04-21 2007-11-01 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Transdermal delivery system comprising sufentanil and its analogues
US20070278289A1 (en) * 2006-05-31 2007-12-06 Toshiba Tec Kabushiki Kaisha Payment adjusting apparatus and program therefor
US20080004671A1 (en) * 2006-06-28 2008-01-03 Alza Corporation Vagus nerve stimulation via orally delivered apparatus
TWI433674B (zh) 2006-12-28 2014-04-11 Infinity Discovery Inc 環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類
FR2912643B1 (fr) * 2007-02-15 2009-04-17 Dbv Technologies Sa Patch pour application cutanee
JP5192722B2 (ja) * 2007-04-27 2013-05-08 祐徳薬品工業株式会社 外用貼付剤
WO2009005814A2 (en) * 2007-07-03 2009-01-08 Marchitto Kevin S Drug-delivery patch comprising a dissolvable layer and uses thereof
RU2472539C2 (ru) 2007-08-06 2013-01-20 Аллерган, Инк. Способы и устройства для доставки препарата десмопрессина
NZ584190A (en) * 2007-10-15 2012-09-28 Alza Corp Once-a-day replacement transdermal administration of fentanyl
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
EP2246054B1 (de) 2008-01-28 2018-06-13 Teikoku Seiyaku Co., Ltd. Fentanylhaltiges pflaster zur äusserlichen anwendung
EP2111857A1 (de) 2008-04-25 2009-10-28 Acino AG Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff hiervon
LT3225249T (lt) 2008-05-21 2019-01-10 Ferring B.V. Burnoje disperguojamas desmopresinas, skirtas pirminio miego periodo, nepertraukiamo nikturija, pailginimui
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
CN101780057B (zh) * 2009-01-21 2012-09-05 考司美德制药株式会社 经皮吸收贴剂
AU2010274374B2 (en) 2009-07-24 2014-08-14 Teikoku Seiyaku Co., Ltd. Fentanyl-containing adhesive preparation for external use
EP2295046B1 (de) 2009-09-14 2012-12-19 Acino AG Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon
AU2011239636A1 (en) 2010-04-13 2012-11-22 Najib Babul Dermal pharmaceutical compositions of 1-Methyl-2',6'-pipecoloxylidide and method of use
EP2462927A1 (de) 2010-12-03 2012-06-13 Hexal AG Transdermales therapeutisches System mit Fentanyl
KR20120107153A (ko) 2011-03-15 2012-10-02 아이큐어 주식회사 펜타닐 경피 패치제
EP2759294B1 (de) * 2011-09-22 2017-11-01 Samyang Biopharmaceuticals Corporation Perkutan absorbierbares präparat mit fentanyl und einem homolog davon
EP2599478A1 (de) 2011-11-30 2013-06-05 Acino AG Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon
WO2016009064A1 (en) 2014-07-18 2016-01-21 Buzzz Pharmaceuticals Limited Abuse deterrent opiod/opiod-antagonist transdermal patch
RU2700032C2 (ru) * 2014-08-25 2019-09-12 ХЕНКЕЛЬ АйПи ЭНД ХОЛДИНГ ГМБХ Акриловые полимеры и их применение при трансдермальной доставке лекарственного средства
EP3233081B1 (de) 2014-12-19 2021-09-22 Kindeva Drug Delivery L.P. Transdermale arzneimittelverabreichungsvorrichtung enthaltend fentanyl
US10010543B1 (en) 2014-12-23 2018-07-03 Barr Laboratories, Inc. Transdermal dosage form
EP3067050A1 (de) 2015-03-13 2016-09-14 Acino AG Transdermales therapeutisches system mit einem overtape mit zwei haftschichten
MX2017015681A (es) * 2015-06-04 2018-09-11 Pellepharm Inc Formulaciones topicas para suministrar compuestos inhibidores de hedgehog y uso de los mismos.
US9650338B1 (en) 2016-07-29 2017-05-16 VDM Biochemicals, Inc. Opioid antagonist compounds and methods of making and using
WO2018115535A1 (es) 2016-12-19 2018-06-28 Nutritape, S.L. Parche energizante para deportistas
EP3612495B1 (de) 2017-04-18 2022-07-13 Breakthrough Technologies, LLC Schwefelherstellung
WO2020008370A1 (en) 2018-07-02 2020-01-09 Clexio Biosciences Ltd. Transdermal patch
WO2020008366A1 (en) 2018-07-02 2020-01-09 Clexio Biosciences Ltd. Transdermal dosage form
WO2020009685A1 (en) 2018-07-02 2020-01-09 John Tang Transdermal dosage form
RU2712918C1 (ru) * 2019-08-01 2020-02-03 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ предотвращения острой боли при выполнении химического плевродеза после радикальных торакопластических операций онкологического характера
CN110693857B (zh) * 2019-10-17 2023-08-11 宜昌人福药业有限责任公司 一种舒芬太尼透皮贴剂及其制备方法
US11229611B2 (en) 2020-04-30 2022-01-25 Taho Pharmaceuticals Ltd. Clobazam transdermal delivery system and uses thereof
RU204475U1 (ru) * 2020-09-24 2021-05-26 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт медицины труда имени академика Н.Ф. Измерова" (ФГБНУ "НИИ МТ") Медицинский аппликатор для местного лечения кожных заболеваний
US11369789B2 (en) 2021-04-05 2022-06-28 Ishaan Jain Transdermal drug delivery system

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3352708A (en) * 1964-03-02 1967-11-14 Ball Brothers Co Inc Glass having dual protective coatings thereon and method for forming such coatings
US3886126A (en) * 1973-04-09 1975-05-27 Monsanto Co Solutions of pressure-sensitive resin solutions with improved viscosity and flow
US3900610A (en) * 1973-04-09 1975-08-19 Monsanto Co Process of making a pressure sensitive adhesive article
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
JPS57142258A (en) * 1981-02-27 1982-09-02 Nitto Electric Ind Co Drug containing tape preparation
US5310559A (en) * 1982-09-01 1994-05-10 Hercon Laboratories Corporation Device for controlled release and delivery to mammalian tissue of pharmacologically active agents incorporating a rate controlling member which comprises an alkylene-alkyl acrylate copolymer
US4704282A (en) * 1984-06-29 1987-11-03 Alza Corporation Transdermal therapeutic system having improved delivery characteristics
US4725439A (en) * 1984-06-29 1988-02-16 Alza Corporation Transdermal drug delivery device
US4588580B2 (en) * 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4954343A (en) * 1986-03-29 1990-09-04 Nitto Electric Industrial Co., Ltd. Dermal pharmaceutical preparations
US5560922A (en) * 1986-05-30 1996-10-01 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process
US5344656A (en) * 1986-09-12 1994-09-06 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US4908027A (en) * 1986-09-12 1990-03-13 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US4906463A (en) * 1986-12-22 1990-03-06 Cygnus Research Corporation Transdermal drug-delivery composition
AU607172B2 (en) * 1986-12-22 1991-02-28 Cygnus, Inc. Diffusion matrix for transdermal drug administration
US5006342A (en) * 1986-12-22 1991-04-09 Cygnus Corporation Resilient transdermal drug delivery device
US4822802A (en) * 1987-02-24 1989-04-18 Alza Corporation Method of fentanly administration for postoperative pain relief
US5186939A (en) * 1987-04-23 1993-02-16 Cygnus Therapeutic Systems Laminated composite for transdermal administration of fentanyl
JPH0818975B2 (ja) * 1987-06-08 1996-02-28 日東電工株式会社 疾患治療用貼付剤
DE3729299A1 (de) * 1987-09-02 1989-03-23 Beiersdorf Ag Transdermales therapeutisches system
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US4994267A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5364630A (en) * 1988-06-14 1994-11-15 Alza Corporation Subsaturated nicotine transdermal therapeutic system
US5004610A (en) * 1988-06-14 1991-04-02 Alza Corporation Subsaturated nicotine transdermal therapeutic system
CA2065311C (en) * 1989-09-08 2000-01-11 Chia-Ming Chiang Solid matrix system for transdermal drug delivery
JP3046346B2 (ja) * 1990-03-12 2000-05-29 昭和電工株式会社 外用剤基剤又は補助剤とそれを含有する人又は動物の外用剤
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
US5152997A (en) * 1990-12-11 1992-10-06 Theratech, Inc. Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels
US5164190A (en) * 1990-12-11 1992-11-17 Theratech, Inc. Subsaturated transdermal drug delivery device exhibiting enhanced drug flux
RU2056865C1 (ru) * 1992-02-25 1996-03-27 Новокузнецкий филиал Института общей реаниматологии РАМН Способ лечения печеночной недостаточности у больных с эндо- и экзогенными токсикозами
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
US5762952A (en) * 1993-04-27 1998-06-09 Hercon Laboratories Corporation Transdermal delivery of active drugs
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
US5554381A (en) * 1993-08-09 1996-09-10 Cygnus, Inc. Low flux matrix system for delivering potent drugs transdermally
CA2165802A1 (en) * 1993-09-29 1995-04-06 Eun Soo Lee Monoglyceride/lactate ester permeation enhancer for oxybutynin
EP0781122B1 (de) 1994-09-14 2000-07-05 Minnesota Mining And Manufacturing Company Matrix für transdermale wirkstofffreisetzung
US5714162A (en) * 1994-09-16 1998-02-03 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Scopolamine patch
KR100188180B1 (ko) * 1994-12-24 1999-06-01 서경배 경피투여용 패취제제
US6154190A (en) * 1995-02-17 2000-11-28 Kent State University Dynamic drive methods and apparatus for a bistable liquid crystal display
US5882676A (en) * 1995-05-26 1999-03-16 Alza Corporation Skin permeation enhancer compositions using acyl lactylates
US6093419A (en) * 1995-06-07 2000-07-25 Lectec Corporation Compliance verification method and device in compulsory drug administration
US5693335A (en) * 1995-06-07 1997-12-02 Cygnus, Inc. Skin permeation enhancer composition for use with sex steroids
US5785991A (en) * 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
DE19527925C2 (de) * 1995-07-29 1997-07-03 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer trennmittelbeschichteten Schutzschicht
US5900198A (en) * 1996-01-31 1999-05-04 Hori; Yasunori Method of producing molded resin product
TW411277B (en) * 1996-05-13 2000-11-11 Hisamitsu Pharmaceutical Co Percutaneous tape preparation containing fentanyl
JP3836566B2 (ja) * 1996-05-13 2006-10-25 久光製薬株式会社 フェンタニル含有経皮投与テープ製剤
US5985317A (en) * 1996-09-06 1999-11-16 Theratech, Inc. Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
AU4990797A (en) * 1996-10-24 1998-05-15 Alza Corporation Permeation enhancers for transdermal drug delivery compositions, devices, and methods
DE19653605C2 (de) * 1996-12-20 2002-11-28 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems
DE19653606A1 (de) * 1996-12-20 1998-06-25 Roehm Gmbh Haft- und Bindemittel aus (Meth)acrylatpolymer, organischer Säure und Weichmacher
US6203817B1 (en) * 1997-02-19 2001-03-20 Alza Corporation Reduction of skin reactions caused by transdermal drug delivery
US5948433A (en) * 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
IT1294748B1 (it) * 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
US6210705B1 (en) * 1997-12-15 2001-04-03 Noven Pharmaceuticals, Nc. Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
AU1728099A (en) * 1997-12-22 1999-07-12 Alza Corporation Monoglyceride and ethyl palmitate permeation enhancer compositions
KR19980025307A (ko) * 1998-04-11 1998-07-06 조태임 진통효과를 갖는 약물의 경피흡수제제
PT1061900E (pt) * 1999-01-14 2005-04-29 Noven Pharma Composicoes e metodos para libertacao de uma droga
JP4643018B2 (ja) * 1999-04-13 2011-03-02 久光製薬株式会社 経皮吸収型製剤
IT1312198B1 (it) * 1999-04-21 2002-04-09 De Nora Spa Cella a combustibile raffreddata mediante iniezione diretta di acqualiquida
US20030178031A1 (en) * 1999-05-07 2003-09-25 Du Pen, Inc. Method for cancer pain treatment
KR20010036685A (ko) * 1999-10-11 2001-05-07 김윤 펜타닐을 함유하는 매트릭스형 경피투여제
US6383511B1 (en) * 1999-10-25 2002-05-07 Epicept Corporation Local prevention or amelioration of pain from surgically closed wounds
US6455066B1 (en) * 2000-03-10 2002-09-24 Epicept Corporation Intradermal-penetration agents for topical local anesthetic administration
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
MXPA03008349A (es) * 2001-03-16 2004-10-15 Johnson & Johnson Parche transdermico para administrar fentanilo.
US20050208117A1 (en) * 2001-03-16 2005-09-22 Venkatraman Subramanian S Transdermal administration of fentanyl and analogs thereof
DE10141650C1 (de) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
WO2003074035A1 (de) * 2002-03-06 2003-09-12 Hexal Ag Transdermalsystem mit fentanyl
TW200404581A (en) * 2002-04-23 2004-04-01 Alza Corp Transdermal analgesic systems with reduced abuse potential
TWI296531B (en) * 2002-10-18 2008-05-11 Hisamitsu Pharmaceutical Co Transdermal adhesive preparations for topical administration of fentanyl
US20040086551A1 (en) * 2002-10-30 2004-05-06 Miller Kenneth J. Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
DE10252725A1 (de) * 2002-11-13 2004-06-03 Lts Lohmann Therapie-Systeme Ag Feuchtigkeitsaktivierbare Klebstoffe für medizinische Anwendungszwecke
EP2269606A3 (de) * 2003-10-30 2012-04-25 ALZA Corporation Transdermale analgesische Systeme mit reduziertem Missbrauchspotential
JP4745747B2 (ja) * 2004-08-12 2011-08-10 日東電工株式会社 フェンタニル含有貼付製剤
US8252328B2 (en) * 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery

Also Published As

Publication number Publication date
RU2003127841A (ru) 2005-03-27
CN1535142A (zh) 2004-10-06
KR20030082995A (ko) 2003-10-23
PL363079A1 (en) 2004-11-15
CN101524339A (zh) 2009-09-09
DE02715112T1 (de) 2007-04-19
DE60220661T2 (de) 2008-02-14
JP2011037884A (ja) 2011-02-24
IL243302A0 (en) 2016-02-29
AT9258U2 (de) 2007-07-15
MXPA03008349A (es) 2004-10-15
ZA200308026B (en) 2004-10-15
JP2017014268A (ja) 2017-01-19
US20140030316A1 (en) 2014-01-30
CZ20032813A3 (cs) 2004-08-18
ES2270746T1 (es) 2007-04-16
IL157822A (en) 2016-05-31
KR100904158B1 (ko) 2009-06-23
DE20221841U1 (de) 2008-05-21
CZ307857B6 (cs) 2019-07-03
US20210113541A1 (en) 2021-04-22
US20030026829A1 (en) 2003-02-06
JP2014224145A (ja) 2014-12-04
JP2020023541A (ja) 2020-02-13
AT8273U1 (de) 2006-05-15
DK200500030Y4 (da) 2006-07-28
CY1106834T1 (el) 2012-05-23
AU2002247331C1 (en) 2002-10-03
US20040213832A1 (en) 2004-10-28
US20190167655A1 (en) 2019-06-06
US20160331740A1 (en) 2016-11-17
AT8585U2 (de) 2006-10-15
US20200289488A1 (en) 2020-09-17
WO2002074286A1 (en) 2002-09-26
CN100508974C (zh) 2009-07-08
JP2018109021A (ja) 2018-07-12
JP2012197302A (ja) 2012-10-18
EP1381352A1 (de) 2004-01-21
US20090004257A1 (en) 2009-01-01
IL157822A0 (en) 2004-03-28
FI6962U1 (fi) 2006-02-13
FIU20050202U0 (fi) 2005-06-02
AT9258U3 (de) 2008-05-15
DK1381352T3 (da) 2007-07-09
JP5950704B2 (ja) 2016-07-13
NZ528148A (en) 2006-02-24
RU2007113373A (ru) 2008-10-27
RU2708563C2 (ru) 2019-12-10
FIU20060295U0 (fi) 2006-07-11
US20180098979A1 (en) 2018-04-12
JP2004524336A (ja) 2004-08-12
JP6437971B2 (ja) 2018-12-12
CA2440884A1 (en) 2002-09-26
HK1068545A1 (en) 2005-04-29
JP5354763B2 (ja) 2013-11-27
FI7341U1 (fi) 2006-12-27
DK200500030U1 (da) 2005-05-13
US20200054619A1 (en) 2020-02-20
ES2270746T3 (es) 2007-12-01
EP1381352B1 (de) 2007-06-13
PT1381352E (pt) 2007-07-27
AT8585U3 (de) 2007-02-15
ATE364380T1 (de) 2007-07-15
RU2351318C2 (ru) 2009-04-10
US20140271799A1 (en) 2014-09-18
DK200500030U3 (da) 2005-07-22
CA2440884C (en) 2012-05-22

Similar Documents

Publication Publication Date Title
DE60220661D1 (de) Transdermales pflaster zur verabreichung von fentanyl
DE60115418D1 (de) Mikroinfusionsvorrichtung zur verabreichung von medikamenten
DE60325715D1 (de) Methoden und darreichungsformen zur kontrollierten freisetzung von oxykodon
ATE449599T1 (de) Zusammensetzung zur transdermalen verabreichung von fentanyl
ATE296619T1 (de) Feste orale dosierungsform von simethicon
DE50206657D1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
DE60333294D1 (de) Kontrollierte verabreichung von arzneien
FI20011478A (fi) Farmaseuttinen koostumus
DE602004020901D1 (de) System zur Einführung von mehreren Medizinprodukten
EE200300416A (et) Ravimvorm
NO20033384L (no) Farmasoytisk formulering
DE60126838D1 (de) Amidoacetonitrile zur Bekämpfung von Endoparasiten
DE60126321D1 (de) Gelsystem zur ocularen verabreichung von arzneimitteln
NO20034311D0 (no) CCR5-antagonister for behandling av AIDS
DE60317887D1 (de) System zur verabreichung therapeutischer substanzen
EE05020B1 (et) Glburiidi ravimkoostis
DE60229668D1 (de) Pflaster zur freisetzung von flüchtigen substanzen in die umgebung
DE60318831D1 (de) System zur abgabe von anästhetika
DE50209245D1 (de) Neuroprotektives medikament
DE60327447D1 (de) Pflaster
DE602004012925D1 (de) Protokoll zur Erbringung von Diensten
FI20022128A (fi) Farmaseuttinen koostumus
DE60237018D1 (de) Mikroröhrchen zur therapeutischen abgabe
DE50108168D1 (de) Transdermales therapeutisches system zur abgabe von lerisetron
DK1475379T3 (da) Anvendelse af scopinesterderivater til fremstilling af lægemidler

Legal Events

Date Code Title Description
8363 Opposition against the patent